As part of a study of the immune defect related to the absence of purine nucleoside phosphorylase, the substrate analogue 6-hydroxy-9-p-aminobenzylpurine was synthesized. This inosine analogue was a competitive inhibitor with an inhibition constant of about 200 muM. Using trichloro-s-triazine, the inhibitor was coupled to Sepharose, producing an efficient, reusable biospecific affinity gel. The gel was used to purify purine nucleoside phosphorylase from human red cells with an 85% yield and a specific activity of 95 mumol/min/mg. The molecular weight of native purine nucleoside phosphorylase was estimated as 90,400 using high pressure liquid chromatography. A subunit molecular weight of 31,600 was established using sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Thus, a trimeric structure for the native enzyme is indicated, which is in accordance with the evidence derived from genetic studies.
No takes yet. Share an insight, caveat, or question.
William R.A. Osborne (1980) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: